PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 52 filers reported holding PASSAGE BIO INC in Q4 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $762 | -41.2% | 961,271 | 0.0% | 0.00% | -60.0% |
| Q1 2024 | $1,296 | +112.5% | 961,271 | +59.0% | 0.01% | +150.0% |
| Q4 2023 | $610 | +54.0% | 604,678 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $396 | -27.1% | 604,678 | +4.5% | 0.00% | 0.0% |
| Q2 2023 | $543 | -1.8% | 578,806 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $553 | -30.7% | 578,806 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $798 | -99.9% | 578,806 | +16.3% | 0.00% | +33.3% |
| Q3 2022 | $620,000 | -37.4% | 497,553 | +18.6% | 0.00% | -40.0% |
| Q2 2022 | $990,000 | +99.6% | 419,564 | +161.8% | 0.01% | +150.0% |
| Q1 2022 | $496,000 | – | 160,259 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,959,769 | $49,399,000 | 20.45% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,185,869 | $11,811,000 | 9.97% |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $24,879,000 | 7.18% |
| FRAZIER MANAGEMENT LLC | 5,009,219 | $49,892,000 | 3.99% |
| Orbimed Advisors | 6,962,899 | $69,350,000 | 0.76% |
| Boxer Capital, LLC | 1,928,315 | $19,206,000 | 0.67% |
| Vivo Capital, LLC | 539,263 | $5,371,000 | 0.24% |
| Logos Global Management LP | 125,010 | $1,245,000 | 0.09% |
| Weiss Multi-Strategy Advisers LLC | 336,034 | $3,347,000 | 0.07% |
| Virtus ETF Advisers LLC | 14,687 | $146,000 | 0.06% |